US domestic manufacturing investment, R&D model shifts, new excipients, and digital traceability are redefining drug ...

The new partnership will work to embed digital identification into labware, solving chain-of-identity challenges for ...

In episode 27, Christopher Hopkins, PhD; Omkar Kawalekar, PhD; Barnaby Pickering; and Jerry Rosenbaum, MD, go behind the ...

For pharmaceutical manufacturers, the most immediate and critical application of RWE is in monitoring post-market safety. The ...

At CPHI and AAPS, Ashland plans to detail the impacts of its advanced excipients: ultra-low nitrite materials curb ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...

Major pharmaceutical investments in the United States are expanding API, capsule, and packaging capacity, enhancing supply chain resilience and supporting domestic drug production.

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

ICE Pharma will present its bile acid-derived innovations and sustainability strategies at CPHI Frankfurt 2025. The company's ...

As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...

This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...